One thing that has been frustrating about chip giant Intel’s (NASDAQ:INTC) current seventh-generation Core processors for personal computers — and what will be frustrating about its upcoming eighth-generation Core processors — is their apparent lack of architectural innovation.
A brief review may be in order. Back in the second half of 2015, Intel introduced a processor....More>>>
Shares of NVIDIA Corporation have fallen over the last few trading sessions. Is this an opportunity to buy NVDA stock on the cheap or is it time to sell? Flickr
The uptrend in the shares of the Santa Clara, California, based NVIDIA Corporation (NASDAQ:NVDA) seems to have come to an abrupt halt. After rising 11% through the year to a peak of $119 February 9, NVDA stock has lost just....More>>>
Related AKS Mid-Morning Market Update: Markets Open Higher; Dollar Tree Profit Beats Estimates Jim Cramer Advises His Viewers On US Steel, AK Steel And Philip Morris Steel Plays Surge To New Highs On Price Strength, Trump Pledges (Investor’s Business Daily) Related X Seeing Uncertainty, Vetr Drops U.S. Steel....More>>>
With viewership rapidly expanding into the hundreds of millions, eSports enjoyed some time in the spotlight at CES 2017 last week. Supernova analyst David Kretzmann was at the trade show in Las Vegas, and he spent some time getting the latest news for this growing industry from the VP and General Manager for eSports at Turner Sports.
Tune in to learn about how the media companies are approaching....More>>>
Sales Trends A Bit Soft, But Nothing To Worry About
I have been a bit disappointed by Nordstroms (NYSE:JWN) recent results. Not because it was a bad quarter per se, but because it broke the sequence of constant overperformance compared to other peers in the
You can make the argument that the Dow Jones Industrial Average isn’t necessarily the best representation of the entire U.S. economy anymore. That title goes to the S&P 500 Index. But you can’t deny that the 30 Dow Jones stocks are kingpins in their respective indus
I have been on and off long Intelsat (I) for some time now. Back in November of 2016 it was my favorite high leveraged stock play (please consider: Intelsat: A High Leveraged Play With Odds In Our Favor).
Then when the stock reached over $5, I sold on the back of the announcement that Inte
For investors looking for huge returns, pharmaceutical stocks may well be the answer. While these stocks are inevitably risky with a lot riding on key clinical results, if trials succeed, the results can be spectacular.